Trial Profile
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Heart failure
- Focus Proof of concept; Therapeutic Use
- Acronyms INDIE-HFpEF
- 11 Mar 2018 According to a Savara Pharmaceuticals media release, Primary endpoint of Peak VO2 has not been met.
- 11 Mar 2018 According to a Savara Pharmaceuticals media release, results from this trial were presented at the American College of Cardiology 67th Annual Scientific Sessions & Expo.
- 19 Jan 2018 Status changed from active, no longer recruiting to completed.